Table 4.
Comparison of LLNAS user and non-user schizophrenia groups
| LLNAS user schizophrenia group (n=75) Median (25–75%) |
YBNAM kullanmayan schizophrenia group (n=25) Median (25–75%) |
Z | p | ||||
|---|---|---|---|---|---|---|---|
| Age at first hospitalization | 20 (16.5–25) | 27.4 (17–29.4) | −2.843 | <0.01 | |||
| Total duration of hospitalization | 4 (2.75–6) | 3.1 (2.4–5.6) | −2.045 | <0.05 | |||
| UKUSERS autonomic | 2 (1–4) | 1.5 (1–3) | −2.032 | <0.05 | |||
| n | % | n | % | X2 | p | ||
| Gender | Female | 17 | 23 | 16 | 64 | 14.488 | <0.001 |
| Male | 58 | 77 | 9 | 36 | |||
| Employment status | Unemployed | 21 | 28 | 17 | 68 | 13.61 | <0.01 |
| Retired | 28 | 37 | 4 | 16 | |||
| Irregular–interrupted | 9 | 12 | 3 | 12 | |||
| Regular–uninterrupted | 17 | 23 | 1 | 4 | |||
| Self-harm | Yes | 17 | 23 | 1 | 4 | 4.43 | <0.05 |
| No | 58 | 77 | 24 | 96 | |||
LLNAS: lifelong nicotine-alcohol-substance; UKUSERS: UKU Side Effect Rating Scale